Nanoparticle drug delivery innovation could enhance drug development
26 December 2024
With advantages such as utilising bio-compatible materials, the biomolecule-based drug delivery system enables potentially safer drug development, according to the researchers.
Antibody drug has promise as “next frontier” in inflammatory bowel disease
26 December 2024
With its best-in-class potential, the biologic could provide a new treatment option for patients with inflammatory bowel disease (IBD), say Teva Pharmaceuticals and Sanofi.
The Ministry of Health suggests establishing a reserve for vaccination complication payments
25 December 2024
The Ministry of Health is modernizing the distribution of funding to regions for compensatory payments to citizens who experience complications after vaccination. The new system creates a centralized financial reserve of 5% of the total funds.
The pharmaceutical industry of St. Petersburg produces medicines worth 110 billion per year
24 December 2024
Vice Governor of St. Petersburg Kirill Polyakov reported on the state and development prospects of the pharmaceutical industry in the city. According to him, the annual volume of shipments by St. Petersburg pharmaceutical companies is 110 billion rubles.
The Federation Council approved the law on decriminalization of medical activities
24 December 2024
The Federation Council of Russia has approved a bill that protects doctors from criminal liability for providing unsafe services under Article 238 of the Criminal Code. This decision was a continuation of the initiative adopted by the State Duma on December 17.
Russian monkeypox drug passes clinical trials
23 December 2024
Russian scientists at the Vector Center have successfully finished clinical trials for NIOKH-14, a new antiviral drug to treat monkeypox. Alexander Agafonov, the center head, announced that after analyzing various molecules, they developed an effective formula for a drug in capsule form.
International Forum of Pharmaceutical Inspectorates: a step toward global harmonization of standards
23 December 2024
The First International Forum of Pharmaceutical Inspectorates has concluded its work in Dubai. It brought together leading experts and representatives of regulatory bodies from the pharmaceutical industry from over 36 countries to discuss key issues related to the circulation of medicines and GMP inspections. The forum was organized by the State Institute of Drugs and Good Practices with the support of the Ministry of Industry and Trade of the Russian Federation.
From January to September 2024, Moscow’s pharmaceutical turnover hit 403.2 billion rubles
20 December 2024
Deputy Mayor of Moscow, Maria Bagreeva, reported that in the first three quarters of 2024, the city’s pharmaceutical industry had a turnover of 403.2 billion rubles, up 38.7% from last year. She believes this result stems from actively adopting innovative developments and modern technologies, which not only compensated for the exit of foreign manufacturers but also led to the creation of unique drugs.
Antibody drug has promise as “next frontier” in inflammatory bowel disease
20 December 2024
With its best-in-class potential, the biologic could provide a new treatment option for patients with inflammatory bowel disease (IBD), say Teva Pharmaceuticals and Sanofi.
Since the start of the year, Russia has registered 84 domestic and 12 foreign veterinary drugs
19 December 2024
In the first ten months of 2024, 84 domestic veterinary drugs and 12 foreign ones were registered in Russia.
Merry Christmas and Happy New Year!
28 December 2024
NovaMedica team in the TOP 100 INFLUENTIAL PEOPLE IN THE PHARMACEUTICAL BUSINESS 2024
28 November 2024
05 November 2024
Enhancing spectroscopy analysis with machine learning
03 February 2025
The production of new Russian “super antibiotic” to begin in Novosibirsk
03 February 2025
A Russian company has started producing 4 veterinary vaccines
31 January 2025
The government held its first meeting on the “New technologies for preserving health” project
31 January 2025